David Seegmiller
Foot & Ankle Surgery · Salt Lake City, UTNPI 1619914751
Payments from drug & device makers
Across 257 payments — averaging $468.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orthofix Medical, Inc.$64K
- Convatec Inc.$30K
- Stryker$23K
- Paragon 28, Inc.$2K
- Sanara Medtech Inc.$239
- Smith+Nephew$175
- plus $1K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orthofix Medical, Inc. | 146 | $63,955 |
| Convatec Inc. | 2 | $29,600 |
| Stryker(2 entities) | 26 | $23,256 |
| Paragon 28, Inc. | 7 | $1,618 |
| Sanara Medtech Inc. | 1 | $239 |
| Smith+Nephew | 13 | $175 |
| Paratek Pharmaceuticals, Inc. | 10 | $171 |
| Imbed Biosciences Inc. | 3 | $161 |
| AbbVie(2 entities) | 8 | $145 |
| Mimedx Group, Inc. | 5 | $110 |
| Organogenesis Inc. | 2 | $110 |
| Urgo Medical North America, LLC | 2 | $101 |
| Vilex LLC | 2 | $88 |
| Integra Lifesciences Corporation | 5 | $87 |
| Medtronic | 1 | $87 |
| Treace Medical Concepts, Inc. | 5 | $70 |
| Amgen | 2 | $51 |
| Merck | 3 | $37 |
| Osiris Therapeutics Inc. | 2 | $35 |
| KCI USA, Inc. | 2 | $34 |
| Nabriva Therapeutics, PLC | 1 | $30 |
| Melinta Therapeutics, LLC | 1 | $28 |
| Nevro Corp. | 1 | $25 |
| Vertex | 1 | $25 |
| Biocomposites Inc | 1 | $22 |
| Aroa Biosurgery Incorporated | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Solventum Corporation | 1 | $18 |
| Arthrosurface Incorporated | 1 | $13 |
| Polynovo North America LLC | 1 | $12 |
How this compares
$120,341 in reported general payments places this provider in the 90th percentile of 104 foot & ankle surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other foot & ankle surgery in Salt Lake City
- Gregory AndersonSalt Lake City$1.6M
- Florian NickischSalt Lake City$474K
- Brian LiljenquistSalt Lake City$263K
- Douglas TooleSalt Lake City$258K
- Grant SunSalt Lake City$11K
- Amanda KhourySalt Lake City$10K
- Callie MorlockSalt Lake City$9K
- Jordan ButterfieldSalt Lake City$7K
- Daniel PreeceSalt Lake City$7K
- Christopher FunkSalt Lake City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.